Stock listing
NASDAQ:CDTX Cidara Therapeutics Inc Stock
Follow Cidara Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:CDTX
$221.32 USD
Close on Jan 5, 2026 · No longer trades
- Lowest – highest close
- $10.17 – $221.32 USDSince Apr 24, 2024 · lowest Oct 15, 2024 · highest Jan 5, 2026
Delisted NASDAQ:CDTX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:CDTX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Cidara Therapeutics Inc on 6ix
- Calls
- 3 calls with a replay · 3 with a transcript · latest Nov 6, 2025
- Decks
- 15 decks · latest Jun 23, 2025
Events
| Call | When | Status |
|---|---|---|
| Cidara Therapeutics (CDTX) Q3 2025 Earnings Call | Thu, Nov 06, 2025 · 5:00 PM ET | Replay |
| Cidara Therapeutics (CDTX) Q2 2025 Earnings Call | Thu, Aug 07, 2025 · 5:00 PM ET | Replay |
| Cidara Therapeutics (CDTX) Q1 2025 Earnings Call | Thu, May 08, 2025 · 5:00 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Corporate Update (June 2025) | Corporate update | 12 slides | Jun 23, 2025 |
| Investor Presentation (May 2024) | Investor deck | 63 slides | May 3, 2024 |
| Investor Day (September 2023) | Investor day | 58 slides | Sep 21, 2023 |
| Investor Day (July 2022) | Investor day | 57 slides | Jul 7, 2022 |
| Technical Presentation (December 2021) | Technical | 24 slides | Dec 14, 2021 |
| Investor Day (September 2021) | Investor day | 110 slides | Sep 21, 2021 |
| 19th Annual Needham Virtual Healthcare Conference 2020 | Conference | 38 slides | Apr 14, 2020 |
| Investor Presentation (January 2020) | Investor deck | 51 slides | Jan 13, 2020 |
| Investor Day (November 2019) | Investor day | 96 slides | Nov 14, 2019 |
| Investor Presentation (August 2019) | Investor deck | 46 slides | Aug 14, 2019 |
All 15 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (July 2019) | Technical | 14 slides | Jul 29, 2019 |
| Technical Presentation (March 2018) | Technical | 15 slides | Mar 19, 2018 |
| Investor Day (April 2017) | Investor day | 174 slides | Apr 6, 2017 |
| Investor Presentation (January 2017) | Investor deck | 34 slides | Jan 9, 2017 |
| Leerink Partners Rare Disease & Immuno-Oncology Conference 2016 | Conference | 27 slides | Sep 28, 2016 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Rajeev M Shah Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Wave Life Sciences Ltd. (Director · Since at least Aug 16, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); POINT Biopharma Global Inc (Director · Jun 23, 2021 – Jun 29, 2021 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Black Diamond Therapeutics, Inc. (Director · Jan 29, 2020 – Jul 5, 2023 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 6, 2023 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – May 27, 2020 · Past); Solid Biosciences Inc. (Director · Jan 25, 2018 – Jan 11, 2024 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 17, 2021 · Past); KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Oct 25, 2016 – Apr 2, 2020 · Past) | Director · Since at least Apr 24, 2024 |
| Frank Karbe Other companies: Phathom Pharmaceuticals, Inc. (Director · Since at least Apr 25, 2022); Better Therapeutics, Inc. (Chief Executive Officer, Director · Jul 5, 2022 – Dec 18, 2023 · Past); Aduro Biotech Inc (Director · Apr 18, 2019 – May 5, 2020 · Past); Myovant Sciences Ltd (Principal Fin'l & Accounting · Oct 26, 2016 – Jul 7, 2021 · Past); Arbutus Biopharma Corporation (Director · Dec 31, 2014 – Jun 21, 2017 · Past); Exelixis, Inc. (EVP and CFO · Dec 8, 2006 – Feb 15, 2014 · Past) | Chief Financial Officer · Since at least Feb 24, 2025 |
| Scott M Rocklage Other companies: Aprea Therapeutics, Inc. (Director · Oct 2, 2019 – Jun 30, 2020 · Past); Pulmatrix, Inc. (Director · Jun 15, 2015 – Feb 3, 2016 · Past); EPIRUS Biopharmaceuticals Inc (Director · Jul 15, 2014 – Jun 5, 2015 · Past); Achaogen Inc (Director · Mar 11, 2014 – Mar 11, 2014 · Past); Relypsa Inc (Director · Nov 14, 2013 – Nov 20, 2013 · Past) | Director · Apr 14, 2015 – Jun 13, 2018 · Past |
| Joshua Resnick Other companies: Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); PepGen Inc. (Director · Since at least Jun 20, 2024); Jade Biosciences, Inc. (Director · Jun 5, 2024 – Jun 5, 2024 · Past); Vor Biopharma Inc. (Director · May 23, 2024 – May 22, 2025 · Past) | Director · Since at least Jan 3, 2025 |
| Matthew Onaitis Other companies: Trius Therapeutics Inc (General Counsel · May 31, 2012 – Sep 11, 2013 · Past); Somaxon Pharmaceuticals Inc (SVP, General Counsel · May 15, 2006 – Dec 31, 2012 · Past) | Gnrl Counsel, CFO & Secretary · Jul 1, 2016 – Mar 29, 2018 · Past |
| Timothy R Franson Other companies: Paratek Pharmaceuticals Inc (Director · Jul 21, 2015 – Sep 21, 2023 · Past); Myrexis Inc (Director · Nov 11, 2010 – Dec 8, 2011 · Past) | Director · Apr 14, 2015 – Jun 22, 2023 · Past |
| Jeffrey Stein Other companies: IDEAYA Biosciences, Inc. (Director · Since at least Jun 24, 2025) | President & CEO, Director · Since at least Mar 31, 2025 |
| Jessica Oien Other companies: Boundless Bio, Inc. (Chief Legal Officer · Since at least Mar 27, 2024) | General Counsel & Secretary · Dec 3, 2018 – Mar 17, 2021 · Past |
| Ryan Spencer Other companies: Dynavax Technologies Corporation (CEO and Director, Director · Since at least Feb 4, 2024) | Director · Since at least Apr 24, 2024 |
| Brady Johnson | Vice President, Finance · Aug 17, 2018 – Mar 31, 2022 · Past |
All 16 people
| Person | Seat |
|---|---|
| Carin Canale-Theakston | Director · Since at least Jan 22, 2021 |
| Chrysa Mineo | Director · Since at least Jun 22, 2022 |
| Kevin Forrest | Chief Scientific Officer · Nov 23, 2015 – Mar 31, 2017 · Past |
| Nicole Negar Davarpanah | Chief Medical Officer · Since at least May 1, 2025 |
| Paul Daruwala | Chief Operating Officer · Sep 12, 2019 – Sep 12, 2022 · Past |
| Shane Ward | COO & CLO · Since at least Mar 31, 2025 |
Log in to ask 6ix AI your own questions about Cidara Therapeutics Inc.